 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

JagsonpalPharma Standalone September 2023 Net Sales at Rs 57.83 crore, down 4.46% Y-o-Y

The 19,600-19,500 zone may be crucial for Nifty and, if this is breached, then correction can be seen towards 19,300. On the higher side, 19,700-19,800 is important to watch out for as a decisive close above 19,800 may take it towards its fresh all-time high

Top 10 bets for August series as Nifty takes a breather but holds pivotal support

JagsonpalPharma Standalone December 2022 Net Sales at Rs 60.14 crore, up 10.4% Y-o-Y

JagsonpalPharma Standalone September 2022 Net Sales at Rs 60.53 crore, up 1.74% Y-o-Y

JagsonpalPharma Standalone June 2022 Net Sales at Rs 60.60 crore, up 1% Y-o-Y

Jagsonpal Pharmaceuticals Ltd. engages in the development and manufacture of intermediate drugs and pharmaceutical formulations. It offers portfolio of drugs focusing on the gynaecology and orthopaedic segments. The company was founded by Jagmohan Singh Kochhar in 1978 and is headquartered in Gurugram, India.

Watchers	13
52-Wk Low	285.00
52-Wk High	514.85

Market Cap	10.9B
Volume (M)	9,965.00
52-Wk High	514.85
52-Wk Low	285.00

JAGSNPHARM.NSE Jagsonpal Pharmaceuticals Ltd.

About

Feed

News

Fundamentals